Moderna’s market value has fallen by more than 90% — $185 billion, or a full Sony — from its 2021 peak to around $10 billion ...
Small study looks only at a cardiac biomarker; findings are in line with reduced myocarditis risk in mRNA COVID vaccines ...
NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...
Mayo Clinic on MSN
COVID-19 vaccines for kids: What you need to know
Learn about the safety and effectiveness of COVID-19 vaccines for kids, the possible side effects, and the benefits of vaccination.
The U.S. kicked off an an unprecedented inoculation campaign this week with a COVID-19 vaccine from Pfizer and its German partner BioNTech. Another vaccine from Moderna, which was co-developed with ...
Moderna is halting development of an mRNA vaccine for congenital cytomegalovirus after its candidate failed to protect women ...
Moderna’s oncology pipeline also includes a Merck-partnered personalized cancer vaccine called intismeran autogene or ...
A shot analysts projected as a multibillion-dollar seller produced results “well below” the company’s expectations, ...
ZURICH, Nov 16 (Reuters) - Swiss contract drug manufacturer Lonza's (LONN.S), opens new tabplants in the United States and Switzerland are due to make ingredients for 400 million doses of Moderna's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results